Do regulatory agencies assess the potential for gene flow and its consequences during their review of crops derived through biotechnology?
Yes. In the U.S., assessing the likelihood and impacts of gene flow is a component of the regulatory review process at both the U.S. Department of Agriculture (USDA) and the Environmental Protection Agency (EPA). Regulatory bodies in other countries also require the submission of data on gene flow probability and its potential impacts.
Related Questions
- Is the recovery plan part of the Services’ other regulatory activities, such as section 7 consultations with Federal agencies?
- What is WER’s status with the U.S. government regulatory and national watchdog agencies?
- Who are the key regulatory agencies that enforce laws relating to Direct Marketing?
